Commentary

Can abuse deterrent formulations make a difference? Expectation and speculation

Simon H Budman , Jill M Grimes Serrano and Stephen F Butler

Inflexxion, Inc 320 Needham St Suite 100, Newton, Massachusetts 02464, USA

author email corresponding author email

Harm Reduction Journal 2009, 6:8doi:10.1186/1477-7517-6-8

Published:	29 May 2009

Abstract

It is critical that issues surrounding the abuse and misuse of prescription opioids be balanced with the need for these medications for the treatment of pain. One way to decrease the abuse of prescription opioid medications is to develop abuse deterrent formulations (or ADFs) that in some way prevent drug abusers from extracting out the active ingredient in order to employ alternate routes of administration, such as injection, snorting, and smoking. Several factors including the pharmacokinetic profile of the drug, the features of the drug formulation that make it attractive or unattractive for abuse, the type of drug abuser, the progression of one's addiction pathway, and one's social environment may all play a role in the abuse of prescription opioids and what methods are used to abuse these drugs. This paper will examine these factors in order to understand how they affect the abuse of prescription opioids and routes of administration, and how the development of ADFs may alter these patterns.